The Scientist

» innovation, immunology and genetics & genomics

Most Recent

image: Scaling to Singles

Scaling to Singles

By | May 1, 2016

Tips for tracing transcription in individual cells

0 Comments

image: Sense and Sensibility

Sense and Sensibility

By | May 1, 2016

Tailored combinations of a reporter and a ligand-binding domain allow for sensing just about any molecule of interest.

0 Comments

image: Sensors for All

Sensors for All

By | May 1, 2016

A versatile modular strategy for detecting small molecules in eukaryotes

0 Comments

image: First Data from Anti-Aging Gene Therapy

First Data from Anti-Aging Gene Therapy

By | April 25, 2016

A biotech company reports that an experimental treatment elongated its CEO’s telomeres. 

8 Comments

image: Study: “Dirty” Mice More Humanlike

Study: “Dirty” Mice More Humanlike

By | April 21, 2016

Housing laboratory mice with those reared in a pet store makes the lab rodents’ immune systems more similar to those of people.

2 Comments

image: AACR Q&A: Angelika Amon

AACR Q&A: Angelika Amon

By | April 19, 2016

The aneuploidy expert shares what she has learned at the American Association for Cancer Research annual meeting.

0 Comments

image: AACR Q&A: Elaine Mardis

AACR Q&A: Elaine Mardis

By | April 18, 2016

The genomics pioneer shares the sessions she most looks forward to at this year’s American Association for Cancer Research annual meeting.

0 Comments

image: Tracking Zika’s Evolution

Tracking Zika’s Evolution

By | April 15, 2016

Sequence analysis of 41 viral strains reveals more than a half-century of change. 

1 Comment

image: Newly Discovered Hormone Explains Disease

Newly Discovered Hormone Explains Disease

By | April 15, 2016

Patients with neonatal progeroid syndrome lack a glucose-releasing hormone, while people with insulin resistance have an abundance.

0 Comments

image: Napster Cofounder Launches Cancer Initiative

Napster Cofounder Launches Cancer Initiative

By | April 13, 2016

Billionaire Silicon Valley entrepreneur Sean Parker donates $250 million to unite the cancer research community around the common goal of developing new immunotherapies.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech